Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol vs Lidocaine for Recovery in FESS
NCT06457100Phase 2Active, not recruiting
- Sponsor
- Huai'an Second Hospital
- Start
- Nov 2023
- Primary completion
- Jun 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of esmolol in chronic rhinosinusitis (CRS), sponsored by Huai'an Second Hospital. Started Nov 2023; status: active, not recruiting.
02
Drugs
esmolol
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT06457100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06457100.